|
7-methoxy-4-{4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1-yl}-5H-pyrimido[5,4-b]indole |
|
Salmonella |
Biofilm |
Preclinical (in vitro) |
Robijns SC, et al. 2012. FEMS Immunol Med Microbiol |
|
7-methyl-4-{4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1-yl}-5H-pyrimido[5,4-b]indole |
Depiction based on curated SMILES
N
N
CH
3
N
N
NH
|
Salmonella |
Biofilm |
Preclinical (in vitro) |
Robijns SC, et al. 2012. FEMS Immunol Med Microbiol |
|
8-fluoro-4-{4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1-yl}-5H-pyrimido[5,4-b]indole |
Depiction based on curated SMILES
N
N
F
N
N
N
H
|
Salmonella |
Biofilm |
Preclinical (in vitro) |
Robijns SC, et al. 2012. FEMS Immunol Med Microbiol |
|
9-methoxy-4-{4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1-yl}-5H-pyrimido[5,4-b]indole |
Depiction based on curated SMILES
HN
N
CH
3
N
N
N
O
|
Salmonella |
Biofilm |
Preclinical (in vitro) |
Robijns SC, et al. 2012. FEMS Immunol Med Microbiol |
|
Pirlindole mesylate |
Depiction based on curated SMILES
HO
O
O
S
CH
3
CH
3
HN
N
|
Salmonella |
Invasion |
Preclinical (in vitro) |
Ridge Y, et al. 2018. J Appl Microbiol |
|
Fenbendazole |
Depiction based on curated SMILES
S
CH
3
N
H
N
N
H
O
O
|
Salmonella |
Invasion |
Preclinical (in vitro) |
Ridge Y, et al. 2018. J Appl Microbiol |
|
N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)-1H-pyrazol-3-yl)propanamide |
Depiction based on curated SMILES
F
F
F
N
H
O
N
N
CH
3
N
N
H
|
Acinetobacter Salmonella |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Moshiri J, et al. 2018. Front Microbiol
|
|
(E)-N'-(3,5-Dibromo-2-hydroxybenzylidene)nicotinohydrazide |
Depiction based on curated SMILES
N
OH
Br
O
Br
N
N
H
|
Chlamydia Escherichia Salmonella |
TTSS (Type III secretion system) TTSS (Type III secretion system) TTSS (SPI-1 encode); TTSS (SPI-2 encode) |
Preclinical (in vitro) Preclinical (in vitro) Preclinical (in vitro) |
Bailey L, et al. 2007. FEBS Lett Tree JJ, et al. 2009. Infect Immun; Wang D, et al. 2011. J Biol Chem Negrea A, et al. 2007. Antimicrob Agents Chemother |
|
Nicotinic acid (5-bromo-2-hydroxy-benzylidene)-hydrazide |
Depiction based on curated SMILES
N
OH
O
Br
N
N
H
|
Salmonella Shigella |
TTSS (SPI-1 encode); TTSS (SPI-2 encode) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Negrea A, et al. 2007. Antimicrob Agents Chemother Veenendaal AK, et al. 2009. J Bacteriol |
|
N-[2-[4-(benzimidazol-1-yl)anilino]-2-oxoethyl]-3-chloro-1-benzothiophene-2-carboxamide |
Depiction based on curated SMILES
N
H
N
N
O
S
Cl
O
N
H
|
Salmonella Yersinia |
TTSS (SPI-1 encode) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vivo) |
Boonyom R, et al. 2022. J Genet Eng Biotechnol Swietnicki W, et al. 2011. PLoS One |
|
| | |